Sartorius Stedim Biotech SA (OTCPK:SDMHF)
$ 220 0 (0%) Market Cap: 21.58 Bil Enterprise Value: 25.42 Bil PE Ratio: 61.22 PB Ratio: 7.19 GF Score: 97/100

Q1 2020 Sartorius AG Earnings Call Transcript

Apr 21, 2020 / 01:30PM GMT
Release Date Price: $230 (+12.77%)
Joachim Kreuzburg
Sartorius Stedim Biotech S.A. - Chairman & CEO

Good afternoon, and good morning, everybody, depending on where you are. Welcome to our conference call on our Q1 results 2020 for both the Sartorius Group as well as for Sartorius Stedim Biotech. As always, I'm sharing this together with Rainer Lehmann, our CFO. And the structure of our presentation is, again, that we first walk you through the results for Sartorius AG or the Sartorius Group, I should say. And then after, we share the information for Sartorius Stedim Biotech, and then we have time for Q&A.

So I would like to start off with highlighting the most important results from Q1. So first of all, we have been able to achieve double-digit growth for all most relevant KPIs: order intake, sales revenue and underlying EBITDA. The impact from the pandemic crisis has been neutral on a group level, but, for sure, was quite different for the 2 divisions, and you'll see that in a minute. For Bioprocess Solutions, we have achieved quite dynamic top line growth, particular strong order intake, because this has been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot